LEADER 04586nam 2200817Ia 450 001 9910968976403321 005 20250910152055.0 010 $a9786610447299 010 $a9780309164849 010 $a0309164842 010 $a9781280447297 010 $a128044729X 010 $a9780309657006 010 $a0309657008 035 $a(CKB)1000000000245217 035 $a(SSID)ssj0000266648 035 $a(PQKBManifestationID)11213428 035 $a(PQKBTitleCode)TC0000266648 035 $a(PQKBWorkID)10304344 035 $a(PQKB)10682368 035 $a(OCoLC)647486865 035 $a(Au-PeEL)EBL3378083 035 $a(CaPaEBR)ebr10120672 035 $a(CaONFJC)MIL44729 035 $a(OCoLC)923275318 035 $a(MiAaPQ)EBC3378083 035 $a(Perlego)4731264 035 $a(BIP)13309875 035 $a(EXLCZ)991000000000245217 100 $a20060117d2006 uy 0 101 0 $aeng 135 $aurcn||||||||| 181 $ctxt 182 $cc 183 $acr 200 00$aValuing health for regulatory cost-effectiveness analysis /$fWilhelmine Miller, Lisa A. Robinson, and Robert S. Lawrence, editors ; Committee to Evaluate Measures of Health Benefits for Environmental, Health, and Safety Regulation, Board on Health Care Services 205 $a1st ed. 210 $aWashington, DC $cNational Academies Press$dc2006 215 $a1 online resource (xvi, 364 pages) $cillustrations, charts 300 $aBibliographic Level Mode of Issuance: Monograph 311 08$aPrint version: Valuing health for regulatory cost-effectiveness analysis. Washington, D.C. : National Academies Press, ©2006 0309100771 (DLC) 2006001486 (OCoLC)63114187 311 08$a9780309100779 311 08$a0309100771 320 $aIncludes bibliographical references and index. 327 $aCharacteristics of major regulations and current analytic practices -- Measures and strategies for obtaaining health benefit values for regulatory analysis -- Beyond ratios: ethical and nonquantifiable aspects of regulatory decisions -- Recommendations for regulatory cost-effectiveness analysis. 330 $aPromoting human health and safety by reducing exposures to risks and harms through regulatory interventions is among the most important responsibilities of the government. Such efforts encompass a wide array of activities in many different contexts: improving air and water quality; safeguarding the food supply; reducing the risk of injury on the job, in transportation, and from consumer products; and minimizing exposure to toxic chemicals. Estimating the magnitude of the expected health and longevity benefits and reductions in mortality, morbidity, and injury risks helps policy makers decide whether particular interventions merit the expected costs associated with achieving these benefits and inform their choices among alternative strategies. Valuing Health for Regulatory Cost-Effectiveness Analysis provides useful recommendations for how to measure health-related quality of- life impacts for diverse public health, safety, and environmental regulations. Public decision makers, regulatory analysts, scholars, and students in the field will find this an essential review text. It will become a standard reference for all government agencies and those consultants and contractors who support the work of regulatory programs. 606 $aMedical care$xCost effectiveness$xResearch$xMethodology 606 $aCost effectiveness 606 $aCost-Benefit Analysis$xmethods$3(DNLM)D003362Q000379 606 $aHealth Policy$xeconomics$3(DNLM)D006291Q000191 606 $aCost-Benefit Analysis$3(DNLM)D003362 606 $aUnited States Government Agencies$3(DNLM)D037041 607 $aUnited States 615 0$aMedical care$xCost effectiveness$xResearch$xMethodology. 615 0$aCost effectiveness. 615 12$aCost-Benefit Analysis$xmethods. 615 22$aHealth Policy$xeconomics. 615 2$aCost-Benefit Analysis. 615 22$aUnited States Government Agencies. 676 $a362.1068/1 701 $aMiller$b Wilhelmine$01809204 701 $aRobinson$b Lisa A$01809205 701 $aLawrence$b Robert S.$f1938-$01806200 712 02$aInstitute of Medicine (U.S.).$bCommittee to Evaluate Measures of Health Benefits for Environmental, Health, and Safety Regulation. 801 0$bMiAaPQ 801 1$bMiAaPQ 801 2$bMiAaPQ 906 $aBOOK 912 $a9910968976403321 996 $aValuing health for regulatory cost-effectiveness analysis$94359869 997 $aUNINA